About Curio Bioscience
Curio Bioscience is a company based in Palo Alto (United States) founded in 2021 by Christina Fan, Ari Chaney, and Stephen Fodor was acquired by Takara Bio in January 2025. Curio Bioscience offers products and services including Seeker and Trekker. Curio Bioscience operates in a competitive market with competitors including Cellworks, Genuity Science, ICarbonX, Rhelixa and Geneyx, among others.
- Headquarter Palo Alto, United States
- Founders Christina Fan, Ari Chaney, Stephen Fodor
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2 M (USD), Grant
Mar 15, 2022
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Takara Bio
(Jan 15, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curio Bioscience
Curio Bioscience offers a comprehensive portfolio of products and services, including Seeker and Trekker.
Provides high-resolution RNA expression mapping for fresh frozen tissues.
Enables single-cell analysis with spatial orientation for genomics research.
Funding Insights of Curio Bioscience
Investors in Curio Bioscience
Curio Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Takara Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector
|
Locked | Locked | Locked |
Investor details for Curio Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curio Bioscience
Investment portfolio details for Curio Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curio Bioscience
Detailed financials for Curio Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curio Bioscience Comparisons
Peer comparison for Curio Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curio Bioscience
Curio Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellworks, Genuity Science, ICarbonX, Rhelixa and Geneyx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosimulation platform developed for therapeutic design in life sciences.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for health management and drug development.
|
|
| Locked | Locked | Locked |
Integrated genomic analysis platform for epigenome data is provided.
|
|
| Locked | Locked | Locked |
Provider of a clinical genetics data management platform for hospitals and genetic labs
|
|
| Locked | Locked | Locked |
Omics clinical data is analyzed through an online platform.
|
Detailed competitors of Curio Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curio Bioscience
Complete news archive for Curio Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curio Bioscience
Curio Bioscience was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Curio Bioscience is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Stephen Fodor is the current CEO of Curio Bioscience. They have also founded this company.
Curio Bioscience was founded in 2021 and is based in Palo Alto, United States. Spatial omics solutions are offered for discovery research within the biotechnology sector. Products including the Curio Seeker bioinformatics pipeline are provided to support spatial transcriptomics analysis. High-resolution mapping is enabled through these tools, by which insights into complex cellular biology are uncovered by researchers.
Curio Bioscience offers Seeker and Trekker.
Curio Bioscience has 2 investors. Key investors include HHS, and Takara Bio.